Changeflow GovPing Healthcare & Life Sciences Microneedle Electrical Interface Patent Granted...
Routine Rule Added Final

Microneedle Electrical Interface Patent Granted to Biolinq

Favicon for changeflow.com USPTO Patent Grants - Medical Devices (A61M)
Published
Detected
Email

Summary

The USPTO granted Patent US12605100B2 to Biolinq Incorporated on April 21, 2026, covering methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure. The patent describes a microneedle-based electrochemical biosensor structure comprising a substrate, microneedle biosensor, primary and secondary electrically conductive elements, and an electrically insulative annular barrier. The patent application (No. 19258472) was filed July 2, 2025, and contains 26 claims.

“A method for circumscribing an insulating barrier region around a singular conductive microneedle structure or plurality of conductive microneedle structures adhered to a fixed substrate for the purpose of spatially defining a conduit for the routing of an electrical signal from the surface of said microneedle or microneedles to the posterior surface of the substrate is disclosed herein.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 39 changes logged to date.

What changed

The USPTO issued Patent US12605100B2 to Biolinq Incorporated, covering methods for creating an isolated electrical interface between microneedle structures and support substrates using an insulating barrier region. The patent describes a biosensor structure with primary and secondary conductive elements separated by an insulative annular barrier to route electrical signals from microneedle surfaces to substrate posterior surfaces.

Medical device manufacturers developing microneedle-based biosensors or electrochemical sensing platforms should review this patent to understand the scope of Biolinq's intellectual property in microneedle signal routing. Companies engaged in similar research or product development in this technical space may need to consider licensing or design-around strategies to avoid potential infringement claims.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure

Grant US12605100B2 Kind: B2 Apr 21, 2026

Assignee

Biolinq Incorporated

Inventors

Joshua Windmiller, James Patrick McCanna, Jared Rylan Tangney

Abstract

A method for circumscribing an insulating barrier region around a singular conductive microneedle structure or plurality of conductive microneedle structures adhered to a fixed substrate for the purpose of spatially defining a conduit for the routing of an electrical signal from the surface of said microneedle or microneedles to the posterior surface of the substrate is disclosed herein. A microneedle-based electrochemical biosensors structure comprises a substrate, a microneedle biosensor, a primary electrically conductive element, a secondary electrically conductive element and an electrically insulative annular barrier.

CPC Classifications

A61M 37/0015 A61M 2037/0053 A61M 2037/0046 A61B 5/14514 A61B 5/150984 A61B 5/685

Filing Date

2025-07-02

Application No.

19258472

Claims

26

View original document →

Get daily alerts for USPTO Patent Grants - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12605100B2

Who this affects

Applies to
Medical device makers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent grant Biosensor development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!